, , , ,

France to speed up re-opening of schools: PM

France will accelerate a plan a plan to re-open high schools and junior high schools across the country, Prime Minister Edouard Philippe said on Thursday.
, , , ,

Spain's COVID-19 deaths edge up to 27,119

Spain's Health Ministry said recorded deaths from the coronavirus reached 27,119 on Thursday, rising by just one for the second day in a row as authorities fine-tune a new methodology for logging cases and deaths.
, , , ,

Coronavirus reproduction rate below one in most of France: minister

The reproduction rate of the coronavirus infection is below 1 in most of France's national territory, Health Minister Olivier Veran said on Thursday.
, , , ,

Health results are good in France regarding coronavirus: PM

Health results have been good so far in France, Prime Minister Edouard Philippe said on Thursday, as the country prepares to enter a second phase in its relaxation of lockdown rules on June 2.
, , , ,

India allows export of paracetamol API: statement

India has ended restrictions on export of active pharmaceutical ingredients (API) of common pain reliever paracetamol, the Directorate General Of Foreign Trade (DGFT) said in a statement on Thursday.
, , , ,

Column: What COVID-19 is teaching us about how to reform Medicare

The COVID-19 pandemic has put a bright spotlight on weaknesses in many of the systems designed to protect Americans from risks. But with older people more susceptible to serious illness and death from the virus, the problems in our Medicare system that...
, , , ,

Takeda gets EU green light to keep bowel drug after Shire buy

Japan's Takeda Pharmaceutical Co Ltd will be allowed to keep a drug used to treat bowel disease because changes in the market have removed the need to sell it to allay EU antitrust concerns over last year's acquisition of Shire plc.
, , , ,

Pfizer ties up with glass maker Corning for vial supply

U.S. drugmaker Pfizer Inc has signed a long-term agreement with glass maker Corning Inc to procure vials for storing drugs, the companies said on Thursday.
, , , ,

AstraZeneca says it may consider exposing vaccine trial participants to virus

The chief executive of AstraZeneca , which is developing a leading coronavirus vaccine with Oxford University, said it is too early to deliberately expose trial participants to the pathogen, but it may become an option if ongoing tests hit a snag.
, , , ,

Moscow's new coronavirus cases fall to lowest in more than a month

The Kremlin on Thursday praised Moscow's authorities after the city reported its lowest daily increase in coronavirus infections since April 23, but some critics raised questions over some of Russia's reported data.
, , , ,

Novartis inks deal to make Mass General Brigham's COVID-19 vaccine candidate

Novartis's gene therapy unit AveXis has signed a manufacturing deal to help produce a novel genetic COVID-19 vaccine candidate being developed by U.S. researchers in Massachusetts, a spokeswoman for the Swiss drugmaker confirmed on Thursday.
, , , ,

Feline good: French cat survives coronavirus infection

Papille purrs contentedly as her owner rubs the back of her head, her coat glossy and her eyes a piercing green - back to her old affection-seeking self after recovering from COVID-19.
, , , ,

Mumbai DJ swaps deck for doctor's scrubs to fight coronavirus

As India's financial capital Mumbai battled a growing number of coronavirus cases, local DJ Sanjay Meriya set aside his turntable and dusted off a long-unused medical degree in order to help out.
, , , ,

AstraZeneca partners with Oxford Biomedica to expand COVID-19 vaccine manufacturing capacity

AstraZeneca has partnered with British cell therapy company Oxford Biomedica to make its experimental COVID-19 vaccine, as the drugmaker looks to bolster its manufacturing capacity to produce one billion doses.
, , , ,

EU plans permanent stockpile of essential drugs, medical gear

The European Commission said on Thursday it wanted to set up a permanent reserve of essential drugs and medical equipment to address shortages that have dogged the EU for years and worsened throughout the COVID-19 pandemic.
, , , ,

LabCorp ties up with software provider to expand virtual clinical trials

Laboratory Corporation of America Holdings (LabCorp) said on Thursday it was partnering with software provider Medable to speed up the adoption of virtual clinical trials, as many participants are dropping out of ongoing studies due to the COVID-19 pan...
, , , ,

Indonesia to keep prescribing two malaria drugs for COVID-19 despite bans in Europe

Indonesia will continue to prescribe two anti-malaria drugs for coronavirus patients but monitor their use closely, a spokesman for Indonesia COVID-19 taskforce said on Thursday, after some European nations banned the drug over safety concerns.
, , , ,

CVS Health to open last of 1,000 drive-thru COVID-19 testing sites

CVS Health Corp said on Thursday it would open more COVID-19 testing sites at some of its pharmacy drive-thru locations, completing the last leg of the drugstore chain's planned 1,000 sites across more than 30 U.S. states.
, , , ,

Oxford BioMedica inks deal to make AstraZeneca's potential COVID-19 vaccine

Britain's Oxford BioMedica has agreed with AstraZeneca to manufacture the drugmaker's experimental COVID-19 vaccine, the cell therapy company said on Thursday.
, , , ,

GSK aims for one billion doses of booster as COVID-19 vaccine race heats up

GSK , the world's largest vaccine maker, laid out plans on Thursday to produce 1 billion doses of vaccine efficacy boosters for COVID-19 shots next year, as the race to develop a successful solution to the coronavirus crisis heats up.
, , , ,

Moderna extends lipids deal to boost COVID-19 vaccine candidate output

Moderna Inc has extended a deal to secure large volumes of the lipids used to produce its experimental COVID-19 vaccine as the U.S. biotech looks to build capacity and produce enough doses to meet expected global demand.
, , , ,

WHO official: European deaths spike since March linked to COVID-19

About 159,000 more people in 24 European countries have died since early March than would have ordinarily been expected, a World Health Organization (WHO) official said on Thursday, with a "significant proportion" of the spike linked to COVID-19.
, , , ,

Africa hit by sustained community spread of coronavirus: disease centre

Cases of community transmission of the new coronavirus are growing in Africa, particularly in Ethiopia, and a new strategy for testing is needed to prevent this, the head of the Africa Centres for Disease Control and Prevention said on Thursday.
, , , ,

Coronavirus patients flood hospitals in Indonesia's second-largest city

Hospitals in Indonesia's second largest city of Surabaya have been overwhelmed by a surge of new coronavirus cases, forcing them to turn patients away, the Indonesian Medical Association said on Thursday.
, , , ,

Exclusive: GSK says science does not link pandemic H1N1 flu vaccine to sleep disorder

British drugmaker GSK said on Thursday that its previous flu pandemic vaccine, which used some of the same ingredients as COVID-19 vaccines currently under development, was not linked to a rise in cases of the sleep disorder narcolepsy.
, , , ,

WHO official: Spike in European deaths since March linked to COVID-19

About 159,000 more people in 24 European countries have died since early March than would have ordinarily been expected, a World Health Organization official said on Thursday, adding a "significant proportion" of the spike is linked to COVID-19.
, , , ,

No preferential access to Themis' potential COVID-19 vaccine: CEO

Nobody will get preferential access to a potential COVID-19 drug developed by vaccine maker Themis Bioscience, which is being bought by U.S. pharmaceuticals firm Merck & Co Inc, the Austrian firm's chief executive said on Thursday.
, , , ,

Amid lockdown, Kenyan medical startup brings clinic to your home

Nathalie Maikere sat at her dining table, her two children playing video games a few feet away, as a doctor in a lab coat unpacked her medical bag and took her temperature, pulse, and blood pressure.
, , , ,

South Korea coronavirus spike stirs second wave concern, social distancing crackdown

South Korea reported 79 new coronavirus cases on Thursday, the most in nearly eight weeks, triggering the return of tougher social distancing curbs amid the spectre of a second wave of disease in a country praised for containing the first outbreak.
, , , ,

French carmaker PSA to make surgical masks at Mulhouse site

French carmaker PSA said on Thursday that it would start manufacturing surgical masks at its site in Mulhouse in eastern France from August.
, , , ,

Malaysia reports 10 new coronavirus cases with no new deaths

Malaysian health authorities reported on Thursday 10 new coronavirus cases, raising the cumulative total to 7,629 cases.
, , , ,

Indonesia reports 687 new coronavirus cases, 23 deaths

Indonesia reported 687 new coronavirus cases, bringing the total number of infections in the Southeast Asian country to 24,538, a health ministry official said on Thursday.
, , , ,

Philippines confirms 539 new coronavirus cases, largest single-day increase

The Philippines' health ministry on Thursday reported 17 more novel coronavirus deaths and 539 new infections, the largest number of cases reported in a single day since the virus was first detected in the country.
, , , ,

GSK aims for 1 billion doses with COVID vaccine booster plan

Britain's GlaxoSmithKline laid out plans on Thursday to produce 1 billion doses of vaccine efficacy boosters, or adjuvants, next year as the race to develop and produce a successful solution to the coronavirus crisis heats up.
, , , ,

Russia's coronavirus death toll passes 4,000

Russia on Thursday reported 174 deaths from the new coronavirus in the previous 24 hours, matching its record daily rise for fatalities and taking the overall death toll to 4,142.
, , , ,

Moderna extends lipids deal to boost COVID-19 vaccine output

Moderna Inc has extended a deal to secure large volumes of the lipids used to produce its experimental COVID-19 vaccine in a bid to meet increasing demand for the medicine, the U.S. biotech company said on Thursday.
, , , ,

Pandemic worsens pain of periods for women across the world: NGO

Millions of women worldwide are facing shortages of sanitary products, price hikes, and worsened stigma while managing periods during the coronavirus pandemic, a charity warned on Thursday.
, , , ,

Roche mixes Actemra with Gilead's remdesivir in COVID-19 trial

Roche plans to test if mixing its anti-inflammation drug Actemra with Gilead Sciences Inc's anti-viral treatment remdesivir works better against severe COVID-19 pneumonia than remdesivir alone, the Swiss drugmaker said on Thursday.
, , , ,

Roche to study remdesivir/Actemra cocktail against severe COVID-19 pneumonia

Swiss drugmaker Roche said on Thursday it would study its anti-inflammation drug Actemra mixed with Gilead Sciences Inc's remdesivir in hospitalised patients with severe COVID-19 pneumonia in a global trial of around 450 patients.